Verve Therapeutics, Inc. - Common Stock (VERV)

Verve Therapeutics is a biotechnology company focused on developing innovative gene-editing therapies aimed at preventing and treating cardiovascular diseases

The company utilizes its proprietary gene-editing technology to precisely target and modify genes associated with high cholesterol and other risk factors for heart disease. By doing so, Verve aims to provide a one-time treatment solution that can significantly reduce the need for lifelong medication and improve long-term health outcomes. With a commitment to transforming the prevention of cardiovascular diseases, Verve Therapeutics is at the forefront of advancing genetic medicine in this critical area of healthcare.